Flyrcado is designed for patients with known or suspected CAD, providing a ready-to-use unit dose that can be manufactured ...

GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a ...

GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...

GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

ARLINGTON HEIGHTS, Ill. - GE HealthCare (NASDAQ: NASDAQ:GEHC) has received U.S. Food and Drug Administration (FDA) approval for Flyrcado™ (flurpiridaz F 18) injection, a new positron emission ...

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments ...

Shares of GE HealthCare Technologies Inc. are ending a good week on a negative note on Friday, after its former parent, now known as GE Aerospace, took advantage of the recent rally to sell off ...

Seamless reading experience. Save your favourite. Global Data forecasts the Indian cardiovascular devices market to grow at a compound annual growth rate of 5 per cent between 2022 and 2030.

The aircraft from Joby Aviation are some of the most advanced in this space, and [Peter Ryseck] set about building a radio-controlled model that flies in the same way. The design is inspired by ...